IFI16 and acute promyelocytic leukemia: The most prominent factors in nuclear antiviral responses, which have been implicated in targeting incoming viral genomes, are components of promyelocytic leukemia nuclear bodies (PML-NBs) and the nuclear DNA sensor IFI16 (interferon gamma inducible protein 16).